These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10667743)

  • 21. Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment.
    Peet M; Laugharne J; Rangarajan N; Reynolds GP
    Int Clin Psychopharmacol; 1993; 8(3):151-3. PubMed ID: 8263312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin E treatment of tardive dyskinesia.
    Adler LA; Peselow E; Rotrosen J; Duncan E; Lee M; Rosenthal M; Angrist B
    Am J Psychiatry; 1993 Sep; 150(9):1405-7. PubMed ID: 8102511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucuna pruriens attenuates haloperidol-induced orofacial dyskinesia in rats.
    Pathan AA; Mohan M; Kasture AS; Kasture SB
    Nat Prod Res; 2011 Apr; 25(8):764-71. PubMed ID: 20635303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.
    Pham DQ; Plakogiannis R
    Ann Pharmacother; 2005 Dec; 39(12):2065-72. PubMed ID: 16288072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia.
    Dabiri LM; Pasta D; Darby JK; Mosbacher D
    Am J Psychiatry; 1994 Jun; 151(6):925-6. PubMed ID: 8185007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms.
    Lohr JB; Cadet JL; Lohr MA; Larson L; Wasli E; Wade L; Hylton R; Vidoni C; Jeste DV; Wyatt RJ
    Schizophr Bull; 1988; 14(2):291-6. PubMed ID: 2904696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence and tardive dyskinesia.
    Soares K; McGrath J; Adams C
    Lancet; 1996 Jun; 347(9016):1696-7. PubMed ID: 8642986
    [No Abstract]   [Full Text] [Related]  

  • 30. Vitamin E in the treatment of tardive dyskinesia.
    Elkashef AM; Ruskin PE; Bacher N; Barrett D
    Am J Psychiatry; 1990 Apr; 147(4):505-6. PubMed ID: 1969247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of tardive dyskinesia and tardive dystonia.
    Simpson GM
    J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-tocopherol in tardive dyskinesia.
    Lohr JB; Cadet JL; Lohr MA; Jeste DV; Wyatt RJ
    Lancet; 1987 Apr; 1(8538):913-4. PubMed ID: 2882306
    [No Abstract]   [Full Text] [Related]  

  • 33. Vitamin E in the treatment of tardive dyskinesia: a replication study.
    Lam LC; Chiu HF; Hung SF
    J Nerv Ment Dis; 1994 Feb; 182(2):113-4. PubMed ID: 8308529
    [No Abstract]   [Full Text] [Related]  

  • 34. alpha-Tocopherol treatment for tardive dyskinesia.
    Spivak B; Schwartz B; Radwan M; Weizman A
    J Nerv Ment Dis; 1992 Jun; 180(6):400-1. PubMed ID: 1593277
    [No Abstract]   [Full Text] [Related]  

  • 35. Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.
    An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Kosten TR; Zhou DF; Yang FD; Zhang XY
    Behav Pharmacol; 2013 Oct; 24(7):610-6. PubMed ID: 23994817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional treatment of tardive dyskinesia.
    Dommisse J
    Am J Psychiatry; 1991 Feb; 148(2):279. PubMed ID: 1987837
    [No Abstract]   [Full Text] [Related]  

  • 37. The current status of tardive dyskinesia.
    Sachdev PS
    Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of tardive dyskinesia.
    Egan MF; Apud J; Wyatt RJ
    Schizophr Bull; 1997; 23(4):583-609. PubMed ID: 9365997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of spirulina maxima on the haloperidol induced tardive dyskinesia and oxidative stress in rats.
    Thaakur SR; Jyothi B
    J Neural Transm (Vienna); 2007 Sep; 114(9):1217-25. PubMed ID: 17530160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.